BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17714114)

  • 1. Assessing the impact of pharmacologic intervention on the quality of life in diabetic peripheral neuropathic pain and fibromyalgia.
    Wu SC; Wrobel JS; Armstrong DG
    Pain Med; 2007 Sep; 8 Suppl 2():S33-42. PubMed ID: 17714114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile of treatment in diabetic peripheral neuropathic pain.
    Robinson-Papp J; Simpson DM
    Pain Med; 2007 Sep; 8 Suppl 2():S43-9. PubMed ID: 17714115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    Perahia DG; Pritchett YL; Desaiah D; Raskin J
    Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?
    Russell JW
    Nat Clin Pract Neurol; 2006 Jan; 2(1):18-9. PubMed ID: 16932514
    [No Abstract]   [Full Text] [Related]  

  • 5. Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
    Terneus W
    J Pain Palliat Care Pharmacother; 2007; 21(1):79-84. PubMed ID: 17430838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic peripheral neuropathic pain: recognition and management.
    Cole BE
    Pain Med; 2007 Sep; 8 Suppl 2():S27-32. PubMed ID: 17714113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine: an emerging evidence for fibromyalgia.
    Pae CU; Marks DC; Han C; Patkar AA; Masand PS
    Biomed Pharmacother; 2009 Jan; 63(1):69-71. PubMed ID: 18502090
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of painful peripheral neuropathy.
    Trivedi JR; Silvestri NJ; Wolfe GI
    Neurol Clin; 2013 May; 31(2):377-403. PubMed ID: 23642715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
    O'Connor AB
    J Pain; 2006 Nov; 7(11):867; author reply 867-8. PubMed ID: 17074629
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.
    García-Campayo J; Serrano-Blanco A; Rodero B; Magallón R; Alda M; Andrés E; Luciano JV; del Hoyo YL
    Trials; 2009 Apr; 10():24. PubMed ID: 19389246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical management strategies for the chronic pain patient.
    Forde G; Stanos S
    J Fam Pract; 2007 Aug; 56(8 Suppl Hot Topics):S21-30. PubMed ID: 18667140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
    Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P
    Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine.
    Hudson JI; Arnold LM; Bradley LA; Choy EH; Mease PJ; Wang F; Ahl J; Wohlreich MM
    J Rheumatol; 2009 Nov; 36(11):2517-22. PubMed ID: 19833743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine (Cymbalta) for diabetic neuropathic pain.
    Med Lett Drugs Ther; 2005 Aug 15-29; 47(1215-1216):67-8. PubMed ID: 16103866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregabalin--a neuromodulator for the treatment of neuropathic pain, generalized anxiety disorders and fibromyalgia syndrome].
    Nymdelger S; Nieber K
    Med Monatsschr Pharm; 2007 Nov; 30(11):396-400. PubMed ID: 18062330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraumatization eliciting the presentation of fibromyalgia.
    Milstein R; Amital D; Arnson Y; Amital H
    Isr Med Assoc J; 2013 Feb; 15(2):123-4. PubMed ID: 23516778
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of depression in the presence of pain symptoms.
    Mohr P; Bitter I; Svestka J; Seifritz E; Karamustafalioglu O; Koponen H; Sartorius N
    Psychiatr Danub; 2010 Mar; 22(1):4-13. PubMed ID: 20305585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine status.
    Fishbain DA
    Pain Med; 2007 Sep; 8 Suppl 2():S25-6. PubMed ID: 17714112
    [No Abstract]   [Full Text] [Related]  

  • 19. Is milnacipran effective in treating pain in patients with fibromyalgia?
    Simon LS
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):126-7. PubMed ID: 16932669
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibromyalgia: poorly understood; treatments are disappointing.
    Prescrire Int; 2009 Aug; 18(102):169-73. PubMed ID: 19746561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.